BLOG

Patent analysis and insight

Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.

Posts about

analytics

The Future of Pharma: The AstraZeneca / Gilead Merger

In early June, AstraZeneca approached rival drugmaker Gilead Sciences to discuss a potential.

Read More

Examiners Who Procrastinate the Most – And How They Can Help You Get Your Next Allowance

Procrastination. We all do it. In-house counsel do it, OCs do it, and USPTO examiners do it. In.

Read More

How to Handle Office Actions More Efficiently

Even during these uncertain times, the USPTO maintains that operations will continue without.

Read More

The Future of Pharma: The AbbVie / Allergan Merger

Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a.

Read More

Examiners Who Love (and Hate) to Interview

Contemplating an interview at the USPTO? Our analysis found that nearly 95% of examiners are.

Read More

7 Tips for Implementing New Legal Tech

Driven by market demand for efficiencies and cost savings, law firms and IP departments are.

Read More

Examiners Who Issue the Most Office Actions

We’re all familiar with Newton’s third law of physics: For every action, there is an equal and.

Read More

The Future of Television: The T-Mobile / Comcast Merger

Executives at T-Mobile may be weighing a potential merger with Comcast, the largest U.S. cable.

Read More

In 2020, Resolve to Streamline Your Patent Practice

Each new year brings a time for reflection and goal setting. Legal teams have a chance to review.

Read More

The Most Common Rejections: 102, 103, and 112(b)

Receiving a rejection for a patent application is no one’s idea of a good time. After spending.

Read More

Are you ready to transform your patent practice?

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.